Haiying Qin

10.4k total citations
41 papers, 2.1k citations indexed

About

Haiying Qin is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Haiying Qin has authored 41 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 18 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Haiying Qin's work include CAR-T cell therapy research (30 papers), Immune Cell Function and Interaction (14 papers) and Acute Lymphoblastic Leukemia research (10 papers). Haiying Qin is often cited by papers focused on CAR-T cell therapy research (30 papers), Immune Cell Function and Interaction (14 papers) and Acute Lymphoblastic Leukemia research (10 papers). Haiying Qin collaborates with scholars based in United States, Canada and China. Haiying Qin's co-authors include Terry J. Fry, Christopher D. Chien, Sang M. Nguyen, Elad Jacoby, Yinmeng Yang, Jack F. Shern, Nirali N. Shah, Thomas J. Fountaine, Maryalice Stetler‐Stevenson and Constance M. Yuan and has published in prestigious journals such as Cell, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Haiying Qin

41 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haiying Qin United States 19 1.6k 742 654 558 468 41 2.1k
Elena Sotillo United States 22 1.6k 1.0× 980 1.3× 588 0.9× 396 0.7× 491 1.0× 45 2.3k
Stefanie R. Bailey United States 19 1.6k 1.0× 699 0.9× 1.1k 1.7× 383 0.7× 468 1.0× 35 2.3k
Christopher D. Chien United States 16 702 0.4× 450 0.6× 302 0.5× 249 0.4× 172 0.4× 32 1.1k
Jason Plotkin United States 8 1.6k 1.0× 603 0.8× 778 1.2× 499 0.9× 569 1.2× 8 2.0k
Thomas Nerreter Germany 13 853 0.5× 387 0.5× 327 0.5× 235 0.4× 322 0.7× 24 1.1k
Kelsey M. Wanhainen United States 10 1.7k 1.0× 551 0.7× 776 1.2× 436 0.8× 582 1.2× 14 1.9k
Evripidis Lanitis Switzerland 19 1.6k 1.0× 695 0.9× 887 1.4× 367 0.7× 562 1.2× 25 2.2k
Orit Itzhaki Israel 22 1.7k 1.0× 627 0.8× 1.2k 1.9× 364 0.7× 157 0.3× 60 2.1k
Kunhong Zhong China 15 638 0.4× 672 0.9× 338 0.5× 179 0.3× 170 0.4× 32 1.4k
Adam S. Sperling United States 22 698 0.4× 1.3k 1.7× 253 0.4× 181 0.3× 146 0.3× 73 2.1k

Countries citing papers authored by Haiying Qin

Since Specialization
Citations

This map shows the geographic impact of Haiying Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiying Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiying Qin more than expected).

Fields of papers citing papers by Haiying Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiying Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiying Qin. The network helps show where Haiying Qin may publish in the future.

Co-authorship network of co-authors of Haiying Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Haiying Qin. A scholar is included among the top collaborators of Haiying Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiying Qin. Haiying Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Balagopalan, Lakshmi, Haiying Qin, Taisuke Kondo, et al.. (2024). Generation of antitumor chimeric antigen receptors incorporating T cell signaling motifs. Science Signaling. 17(846). eadp8569–eadp8569. 5 indexed citations
2.
Cao, Yingying, Reona Okada, Haiying Qin, et al.. (2023). Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma. Journal for ImmunoTherapy of Cancer. 11(1). e005881–e005881. 18 indexed citations
3.
Patterson, Michael T., Natália Schneider, Rochelle Fletcher, et al.. (2022). Murine allogeneic CAR T cells integrated before or early after posttransplant cyclophosphamide exert antitumor effects. Blood. 141(6). 659–672. 4 indexed citations
4.
5.
Kaczanowska, Sabina, Daniel W. Beury, Haiying Qin, & Rosandra N. Kaplan. (2021). 209 Genetically engineered myeloid cells (GEMys) as a platform to enhance antitumor immunity. Regular and Young Investigator Award Abstracts. A220–A220. 1 indexed citations
6.
Kaczanowska, Sabina, Daniel W. Beury, Vishaka Gopalan, et al.. (2021). Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis. Cell. 184(8). 2033–2052.e21. 144 indexed citations
7.
He, Yang, et al.. (2020). Inhibitory effect of 5-FU loaded ultrasound microbubbles on tumor growth and angiogenesis. Bioorganic & Medicinal Chemistry Letters. 30(22). 127534–127534. 3 indexed citations
8.
Ramakrishna, Sneha, Steven L. Highfill, Sang M. Nguyen, et al.. (2019). Modulation of Target Antigen Density Improves CAR T-cell Functionality and Persistence. Clinical Cancer Research. 25(17). 5329–5341. 115 indexed citations
9.
Shah, Nirali N., Haiying Qin, Bonnie Yates, et al.. (2019). Clonal expansion of CAR T cells harboring lentivector integration in the CBL gene following anti-CD22 CAR T-cell therapy. Blood Advances. 3(15). 2317–2322. 104 indexed citations
10.
Hossain, Nasheed, Bita Sahaf, Jay Y. Spiegel, et al.. (2018). Phase I Experience with a Bi-Specific CAR Targeting CD19 and CD22 in Adults with B-Cell Malignancies. Blood. 132(Supplement 1). 490–490. 48 indexed citations
11.
Qin, Haiying, Sang M. Nguyen, Chad Burk, et al.. (2018). Murine pre–B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptor. Blood. 132(18). 1899–1910. 23 indexed citations
12.
Qin, Haiying, Sneha Ramakrishna, Sang M. Nguyen, et al.. (2018). Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22. Molecular Therapy — Oncolytics. 11. 127–137. 200 indexed citations
13.
14.
15.
Qin, Haiying, Waleed Haso, Sang M. Nguyen, & Terry J. Fry. (2015). Preclinical Development of Bispecific Chimeric Antigen Receptor Targeting Both CD19 and CD22. Blood. 126(23). 4427–4427. 19 indexed citations
16.
Qin, Haiying, et al.. (2013). Minor Antigen Distribution Predicts Site-Specific Graft-versus-Tumor Activity of Adoptively Transferred, Minor Antigen-Specific CD8 T Cells. Biology of Blood and Marrow Transplantation. 20(1). 26–36. 8 indexed citations
17.
18.
Qin, Haiying. (2004). Progression of spontaneous autoimmune diabetes is associated with a switch in the killing mechanism used by autoreactive CTL. International Immunology. 16(11). 1657–1662. 18 indexed citations
19.
Qin, Haiying, Masafumi Yamada, Lan Tian, et al.. (2003). Tracking gene expression in primary immunodeficiencies. Current Opinion in Allergy and Clinical Immunology. 3(6). 437–442. 3 indexed citations
20.
Qin, Haiying, Dennis L. Welker, & Nabil N. Youssef. (1993). Isolation and Characterization of a Linear Plasmid from the Entomopathogenic Fungus Ascosphaera apis. Plasmid. 29(1). 19–30. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Sotillo Breakdown of academic impact, for papers by Stefanie R. Bailey Breakdown of academic impact, for papers by Christopher D. Chien Breakdown of academic impact, for papers by Jason Plotkin Breakdown of academic impact, for papers by Thomas Nerreter Breakdown of academic impact, for papers by Kelsey M. Wanhainen Breakdown of academic impact, for papers by Evripidis Lanitis Breakdown of academic impact, for papers by Orit Itzhaki Breakdown of academic impact, for papers by Kunhong Zhong Breakdown of academic impact, for papers by Adam S. Sperling
Rankless by CCL
2026